Expression and prognostic significance of a new tumor metastasis suppressor gene LASS2 in human bladder carcinoma

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1921-1927

  Wang, Haifeng ^a   Wang, Jiansong ^a   Zuo, Yigang ^a   Ding, Mingxia ^a   Yan, Ruping ^a   Yang, Delin ^a   Ke, Changxin ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Bladder carcinoma; Expression; LASS2; Prognostic

Indexed keywords

MESSENGER RNA;

ADULT; ARTICLE; BLADDER CARCINOMA; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HOMO SAPIENS LONGEVITY ASSURANCE HOMOLOG 2 OF YEAST LAG1 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR SUPPRESSOR GENE;

CARCINOMA, TRANSITIONAL CELL; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; SPHINGOSINE N-ACYLTRANSFERASE; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 84872808956     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0026-6     Document Type: Article

References (40)

1. Hisataki T, Miyao N, Masumori N, Takahashi A, Sasai M, et al. Risk factors for the development of bladder cancer after upper tract urothelial cancer. Urology. 2000;55:663-7.
2. Fidler IJ. Critical factors in the biology of human cancer metastasis. Am Surg. 1995;61:1065-6.
3. Saffar H, Sanii S, Heshmat R, Haghpanah V, Larijani B, et al. Expression of galectin-3, nm-23, and cyclooxygenase-2 could potentially discriminate between benign and malignant pheochromocytoma. Am J Clin Pathol. 2011;135:454-60.
4. Park HR, Kim SH, Lee SY, Sung JM, Park AR, et al. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer. 2011;117: 1864-73.
5. Zhang C, Lv F, Zhou L, Li X, Wu XX, et al. Effect of verapamil on the expression of EGFR and NM23 in A549 human lung cancer cells. Anticancer Res. 2009;29:27-32.
6. Jiang WX, Song BG, Wang PJ. Expression of nm23, KAI1 and spiral computed tomography findings in primary gallbladder carcinoma. Chin Med J (Engl). 2009;122:2666-8.
7. Wu CY, Yan J, Yang YF, Xiao FJ, Li QF, et al. Overexpression of KAI1 induces autophagy and increases MiaPaCa-2 cell survival through the phosphorylation of extracellular signal-regulated kinases. Biochem Biophys Res Commun. 2011;404:802-8.
8. Joshi B, Li L, Nabi IR. A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase. J Biol Chem. 2010;285:8830-9.
9. Cao GL, Chu MX, Fang L, Di R, Feng T, et al. Analysis on DNA sequence of KiSS-1 gene and its association with litter size in goats. Mol Biol Rep. 2010;37:3921-9.
10. Hiney JK, Srivastava VK, Les Dees W. Insulin-like growth factor-1 stimulation of hypothalamic KiSS-1 gene expression is mediated by Akt: effect of alcohol. Neuroscience. 2010;166: 625-32.
11. Lee KH, Kim JR. Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer. Oncol Res. 2009;18:107-16.
12. Shoji I, Hirose T, Mori N, Hiraishi K, Kato I, et al. Expression of kisspeptins and kisspeptin receptor in the kidney of chronic renal failure rats. Peptides. 2010;31:1920-5.
13. Nagji AS, Liu Y, Stelow EB, Stukenborg GJ, Jones DR. BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer. J Pathol. 2010;221:229-37.
14. Guo X, Li X, Li F, Feng S, Pan Z, et al. Expression of gene BRMS1 and CD44v6 protein in supraglottic laryngeal carcinoma and its clinical significance. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;23:249-53.
15. Li J, Cheng Y, Tai D, Martinka M, Welch DR, et al. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis. Oncogene. 2011;30:896-906.
16. Metge BJ, Liu S, Riker AI, Fodstad O, Samant RS, et al. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1. Oncology. 2010;78:75-86.
17. Rivera J, Megias D, Navas C, Bravo J. Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor. PLoS One. 2009;4:e6433.
18. Zhao XL, Wang P. [Expression of SATB1 and BRMS1 in ovarian serous adenocarcinoma and its relationship with clinieopathological features]. Sichuan Da Xue Xue Bao Yi Xue Ban 2011; 42:82-85, 105.
19. Frolova N, Edmonds MD, Bodenstine TM, Seitz R, Johnson MR, et al. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Tumour Biol. 2009;30: 148-59.
20. Akakura S, Nochajski P, Gao L, Sotomayor P, Matsui S, et al. Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12. Cell Cycle. 2010;9:4656-65.
21. Zhou Z, Tao T, Ji Y, Yang H, Wang Y, et al. SSeCKS promotes tumor necrosis factor-alpha autocrine via activating p38 and JNK pathways in Schwann cells. Cell Mol Neurobiol. 2010;30:701-7.
22. Su B, Bu Y, Engelberg D, Gelman IH. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C-Raf/MEK/ERK pathway. J Biol Chem. 2010; 285:4578-86.
23. Zan L, Wu H, Jiang J, Zhao S, Song Y, et al. Temporal profile of Src, SSeCKS, and angiogenic factors after focal cerebral ischemia: correlations with angiogenesis and cerebral edema. Neurochem Int. 2011;58:872-9
24. Moon HG, Jeong SH, Ju YT, Jeong CY, Lee JS, et al. Upregulation of RhoGDI2 in human breast cancer and its prognostic implications. Cancer Res Treat. 2010;42:151-6.
25. Zheng Z, Li J, He X, Chen X, Yu B, et al. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil. Hepatogastroenterology. 2010;57:1106-12.
26. Niu H, Li H, Xu C, He P. Expression profile of RhoGDI2 in lung cancers and role of RhoGDI2 in lung cancer metastasis. Oncol Rep. 2010;24:465-71.
27. Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer. 2003;4:51-62.
28. Shevde LA, Welch DR. Metastasis suppressor pathways-an evolving paradigm. Cancer Lett. 2003;198:1-20.
29. Su J, You JF, Zhen J, Cui XL, Fang WG, et al. Overexpression of tumor metastasis suppressor gene 1 suppresses proliferation and invasion, but enhances apoptosis of human breast cancer cells MDA-MB-231 cells. Chin J Pathol. 2007;36:672-676. [in Chinese].
30. Su J, You JF, Zhen J, Cui XL, Fang WG, et al. Studies of tumor metastasis suppressor gene TMSG-1 inhibited proliferation and invasion of prostate cancer. Chin J Cancer 2008;30:404-407. [in Chinese].
31. Chen SH, Bubb MR, Yarmola EG, Zuo J, Jiang J, et al. Vacuolar H + -ATPase binding to microfilaments: regulation in response to phosphatidylinositol 3-kinase activity and detailed characterization of the actin-binding site in subunit B. J Biol Chem. 2004;279:7988-7998.
32. Schiffmann S, Sandner J, Birod K, Wobst I, Angioni C, et al. Ceramide synthases and ceramide levels are increased in breast cancer tissue. Carcinogenesis. 2009;30:745-52.
33. Mesicek J, Lee H, Feldman T, Jiang X, Skobeleva A, et al. Ceramide synthases 2, 5, and 6 confer distinct roles in radiationinduced apoptosis in HeLa cells. Cell Signal. 2010;22:1300-7.
34. Xu XY, Pei F, You JF. TMSG-1 and its roles in tumor biology. Chin J Cancer. 2010;29:697-702.
35. Sobin LH, Wittekind C, editors. TNM classification of malignant tumors. 6th ed. New York: Wiley; 2002.
36. Axiotis CA, Monteagudo C, Merino MJ, LaPorte N, Neumann RD. Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma. Am J Pathol. 1991;138:799-806.
37. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) method. Methods. 2001;25:402-8.
38. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991;64:327-36.
39. Ichikawa T, Ichikawa Y, Isaacs JT. Genetic factors and metastatic potential of prostatic cancer. Cancer Surv. 1991;11:35-42.
40. Tang N, You HY, Jin J. Small interfering RNA targeting LASS2 gene enhances invasion capacity of hepatocellular carcinoma cells. Tumor 2009; 29:399-403. [in Chinese].